NSE: ONESOURCE · 27 October 2026
- Onesource Specialty Pharma has risen 19.18% over 2 trading sessions; today's move is +13.79%.
- Onesource Specialty Pharma Limited has submitted the Exchange a copy Srutinizers report and voting results for the 19th AGM held on September 23, 2026.
- Trading volume was 31.35 times the 20-day average daily volume.
Onesource Specialty Pharma share price: 19.18% rise over 2 trading sessions
Onesource Specialty Pharma Ltd. (ONESOURCE) surged 13.79% on October 27, 2026, closing at ₹1,590.00 after trading within a daily range of ₹1,393.70 and ₹1,604.50.
The broader market benchmark Nifty slipped 0.02% during the session, whereas the sector benchmark Nifty Pharma advanced 2.06%. While the broader market remained flat, Onesource significantly outperformed both the index and its sector peer group, reflecting strong stock-specific momentum.
The sharp rally coincided with the release of the company's Q2FY27 financial results on October 27, 2026, which reported revenue of ₹5,162 million—up 37% year-on-year—and EBITDA of ₹1,633 million, representing a 53% increase year-on-year alongside margin expansion to 32%, driven by new drug-device combination capacity and execution across business segments.
67.81 lakh shares traded by 27 October 2026 · 02:55 PM IST. This compares with a 20-day average daily volume of 2.16 lakh shares (31.35 times). The five-day average daily volume was 1.70 lakh shares. Separately, the NSE report for 26 October 2026 showed 1.46 lakh shares delivered, representing 63.76% of that day’s traded volume. The same report recorded 23,519 trades.
The stock's 13.79% advance aligns directly with the release of strong Q2FY27 results showing 37% YoY revenue growth and 53% YoY EBITDA growth, coupled with elevated trading volumes exceeding 20-day averages by over 31%.
Latest Company Developments
Onesource Specialty Pharma Limited has submitted the Exchange a copy Srutinizers report and voting results for the 19th AGM held on September 23, 2026.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 13.76% on 30 September 2026. This compares with 12.98% on 30 June 2026, a change of +0.78 percentage points.
The filing reported 25 MF/UTI holders.
What to Watch Next
- Commercial ramp-up and execution of the second DDC cartridge line and upcoming line 3 operations
- Progress on new product launches and biopharmaceutical partnerships in North America and international markets
- Sustained delivery percentage trends relative to the 20-day average volume
More Onesource Specialty Pharma news and dated analysis →
Frequently Asked Questions
What is the latest Onesource Specialty Pharma company news?
Onesource Specialty Pharma Limited has submitted the Exchange a copy Srutinizers report and voting results for the 19th AGM held on September 23, 2026.
How strong was Onesource Specialty Pharma’s trading volume?
67.81 lakh shares traded, 31.35 times the 20-day average daily volume. The price and volume data are dated 27 October 2026 · 02:55 PM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.